AlphaFold predicted structure
NSF · P46459

Mean pLDDT
85.6/ 100
Confident
744 residues
Confidence breakdown
- Very high(≥ 90)45%
- Confident(70–90)46%
- Low(50–70)9%
- Very low(< 50)1%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
N-ethylmaleimide sensitive factor, vesicle fusing ATPase
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Early onset or syndromic epilepsy
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknowndevelopmental and epileptic encephalopathy 96
neurodegenerative disease
Abnormality of the skeletal system
atrial fibrillation
androgenetic alopecia
Anxiety
idiopathic pulmonary fibrosis
dermatomycosis
dermatophytosis
functional laterality
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Vesicle-fusing ATPase
Required for vesicle-mediated transport. Catalyzes the fusion of transport vesicles within the Golgi cisternae. Is also required for transport from the endoplasmic reticulum to the Golgi stack. Seems to function as a fusion protein required for the delivery of cargo proteins to all compartments of the Golgi stack independent of vesicle origin. Interaction with AMPAR subunit GRIA2 leads to influence GRIA2 membrane cycling (By similarity)
NSF · P46459

Mean pLDDT
85.6/ 100
Confident
744 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0